Photon-Counting Computed Tomography for Evaluation of Coiled Intracranial Aneurysms.
Date
2025-09-19
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
BACKGROUND AND PURPOSE: Intracranial aneurysms treated with endovascular embolization often require surveillance imaging using digital subtraction angiography, an invasive, risky, and expensive procedure. Existing non-invasive imaging modalities (standard computed tomography [CT] or magnetic resonance [MR] angiography) are often unsatisfactory for evaluating treated aneurysm due to artifacts from embolization devices. The objective of the present study was to determine whether photon-counting computer tomography (PCCT) imaging parameters could be optimized to confer satisfactory imaging resolution in an anthropomorphic phantom of treated intracranial aneurysms. MATERIALS AND METHODS: Phantom studies were performed using a model of the major intracranial arteries with appropriately sized, endovascularly treated middle cerebral artery (coil embolization) and basilar artery (woven endobridge [WEB] embolization) aneurysms. A series of imaging acquisition procedures were performed using a conventional energy-integrating CT (EICT) scanner and a photon-counting CT (PCCT) scanner. Key imaging acquisition and reconstruction parameters were varied to identify the optimum protocol for treated aneurysm characterization. Artifact reduction was performed on all images using the Siemens iterative metal artifact reduction (iMAR) algorithm. Contrast-to-noise ratio and metal artifact magnitude were quantitatively analyzed and displayed in tabular form to provide objective criteria for determination of optimal processing parameters for treated aneurysm visualization. RESULTS: Imaging was successfully obtained in phantom studies across a range of imaging parameters. Quantitative metal artifact magnitude was greater for 100keV virtual monoenergetic images (VMIs) and lowest for 55 keV VMIs without iMAR, but this trend was reversed with iMAR applied. The 55 keV VMI was chosen as the optimal reconstruction parameter for visualization of treated intracranial aneurysms as it demonstrated low magnitude of metal artifacts and the highest contrast-to-noise ratio (CNR) in adjacent vasculature. Similarly, CNR of the largest vessel adjacent to the coil mass was increased for all images after iMAR was applied. CNR was highest in the 55 keV VMR images both before (3.61±0.14) and after (6.82±0.34) application of iMAR. CONCLUSIONS: Virtual monoenergetic images combined with metal artifact reduction algorithms created from PCCT scans conferred excellent visualization of previously-treated intracranial aneurysms and adjacent vasculature. It was feasible to extend these results to preliminary clinical applications in human patients.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Mac Grory, Brian, Amanda Randles, David M Urick, Fides R Schwartz, David Hasan and Evan D Calabrese (2025). Photon-Counting Computed Tomography for Evaluation of Coiled Intracranial Aneurysms. AJNR Am J Neuroradiol. pp. ajnr.A9015–ajnr.A9015. 10.3174/ajnr.A9015 Retrieved from https://hdl.handle.net/10161/33213.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Brian C. Mac Grory
Dr. Brian Mac Grory, MB BCh BAO, MHSc, MRCP, FAHA, FANA is an Associate Professor of Neurology, Ophthalmology & Biomedical Engineering at the Duke University School of Medicine and a Staff Neurologist at Duke University Medical Center. He received his medical degree from University College Dublin in Dublin, Ireland in 2011. After an internship at St. Vincent's University Hospital, Dublin, he completed a neurology residency and vascular neurology fellowship at the Yale School of Medicine/Yale-New Haven Hospital in New Haven, Connecticut. Upon completion of his training, he served for 3 years on the faculty of Brown University/Rhode Island Hospital before being recruited to Duke University in 2020.
His clinical practice encompasses both vascular and general neurology in the emergency, inpatient, outpatient, and telemedicine settings. He has a particular clinical interest in central retinal artery occlusion (CRAO or "eye stroke") and has developed a center of excellence for the treatment of this condition at Duke. He led the development of the first ever American Heart Association (AHA) scientific consensus statement on the management of CRAO which was endorsed by six professional medical societies in the United States representing neurology, neurosurgery, cardiology, ophthalmology, neuro-ophthalmology, and optometry.
Dr. Mac Grory has published over 150 peer-reviewed scientific articles appearing in JAMA, British Medical Journal, Circulation, Stroke, Annals of Neurology, JAMA Neurology, and Neurology. At the Duke Clinical Research Institute, he directs the Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Interdisciplinary Hub. His research on retinal vascular disease is funded by the National Institutes of Health (K23HL161426, UG3NS138219, & R03HL178686), the AHA (23MRFSCD1077188 & 25GLP1450119), and the Duke University Office of the Provost. Additionally, he serves as Clinical Lead for the Get With The Guidelines-Stroke Data Analytic Program at the Duke Clinical Research Institute (DCRI) and Associate Program Director for the vascular neurology fellowship program at Duke. His research has been recognized with the Stroke Progress and Innovation Award, Stroke Care in Emergency Medicine Award, and Early Career Investigator Award from the AHA/American Stroke Association and the Young Physician-Scientist Award from the American Society for Clinical Investigation. He is a member of the AHA's Stroke Systems of Care Advisory Group, the Stroke Emergency Neurovascular Care Committee, and the Royal College of Physicians of the United Kingdom (MRCP(UK)).
Amanda Randles
My research in biomedical simulation and high-performance computing focuses on the development of new computational tools that we use to provide insight into the localization and development of human diseases ranging from atherosclerosis to cancer.
Evan Calabrese
As a physician scientist focused on artificial intelligence (AI) applications for neurologic disease, my ongoing career goal is to combine clinical excellence in neuroradiology with cutting-edge AI research. My primary research interest lies in the use of innovative AI techniques to help extract clinically useful information from multimodal health data with a focus on neuroimaging. Modern neuroimaging studies, most notably multi-sequence MRI, are amongst the largest and most complex types of health data that are routinely acquired for patients with neurologic disorders. I believe that modern AI tools have enormous potential to help extract new, clinically useful information from complex neuroimaging studies, and through integration with other types of health data, will ultimately improve diagnosis, management, and treatment monitoring for patients with neurologic disease.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.
